Contineum Therapeutics elects three Class I directors, ratifies EY as auditor at 2025 annual meeting

Contineum Therapeutics, Inc.

Sarah Boyce elected with 12.7M votes for vs. 641.9K withheld; broker non-votes 2.05M.
Troy Ignelzi elected with 13.2M votes for vs. 112.6K withheld; broker non-votes 2.05M.
Olivia Ware elected with 12.8M votes for vs. 583.7K withheld; broker non-votes 2.05M.
Ratification of Ernst & Young as auditor passed with 15.3M for, 53.9K against, 4.6K abstentions.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.